The nucleotide sequence of the mitochondrial DNA (mtDNA) in the region coding for the 3 1 end of the large rRNA has been determined for two human cell lines bearing independent cytoplasmic chloramphenicol-resistant (CAP-r) mutations. Comparison of the sequences of these two phenotypically d i f f e r e n t CAP-r mutants with t h e i r CAP-sensitive (CAP-s) parental c e l l lines has revealed a single base change for each in a region which i s highly conserved among species. One CAP-r mutation is associated with an A to G transition on the coding strand while the second contains a G to T transversion 52 nucleotides away. Comparable sequence changes in t h i s region had previously been found for mouse and yeast cell mitochondrial CAP-r mutants. Thus, changes in the large rRNA gene eliminate the inhibition of the ribosome by CAP and different nucleotide changes may result in variations in the drug-r phenotype.
INTRODUCTION
CAP-resistant ( r ) mutants have also been isolated for mammalian c e l l s . The f i r s t mutant reported was a HeLa S3 derivative, 296-1 (6) . The CAP-r mutation of 296-1 was shown to be cytoplasmic by enucleation of the CAP-r c e l l s and fusion of the cytoplasmic fragment to CAP-sensitive (s) c e l l s . Selection in CAP and for the recipient cell nucleus yielded viable CAP-r cell lines (cybrids) (7, 8) . The CAP-r locus of 296-1 as well as the CAP-r locus of a mutant of the cell l i n e HT1080 (HT1O2W) were assigned to the mtDNA by demonstrating linkage of the CAP-r phenotype to mtDNA r e s t r i c t i o n endonuclease site polymorphisms (9) . 296-1 and HT1O2W were also observed to differ in the degree of their CAP resistance (9, 10) .
Comparison of the nucleotide sequence of mouse and human mtONAs in the region of the large rRNA surrounding the two yeast CAP-r mutations has revealed a high degree of interspecies sequence homology. Two blocks of sequence homology have been found, one of 10 and one of 13 nucleotides, which are separated by 42 nucleotides. Analysis of the sequence in t h i s same region of the mtDNA of a CAP-r mouse l i n e , 501-1, has also revealed a single nucleotide change close to one of the yeast mutations (11) .
In the present paper we describe a comparable analysis of the mtDNA from the two human CAP-r mutants, 296-1 and HT102W. CAP resistance has also been found to correlate with single nucleotide changes in these lines, though the changes were found to be different in the two mutants.
MATERIALS AND METHODS
Cell Lines, Media and Growth Tests S3 (12), 296-1 ( 6 ) , HT108O (13) and HT102W (9,10) were maintained in MEM (Grand Island Biological Company, Grand Island, N.Y., GIBCO) supplemented with 10% bovine serum (Irvine S c i e n t i f i c , Santa Ana, CA). Media for 296-1 and HT102W were further supplemented with 50 ng/ml CAP. Suspension cultures of 296-1 were grown in MEMS (GIBCO) supplemented with 10% bovine serum, 0.2% glucose and 15mM HEPES (pH = 7.4).
Cloning efficiencies and growth curve procedures have been described previously ( 9 ) . CAP was obtained from Sigma (St. Louis, MO) erythromycin-lactobionate from Abbott Laboratories (North Chicago, I D and carbomycin was a generous g i f t from Mr. Nathan Belcher, Pfeitzer Pharm. Corp., Groton, CO.
MtDNA Purification and Cloning
Mitochondria were isolated by differential centrifugation (14) and the closed circular mtDNA purified by CsCI ethidium bromide (EtBr) gradients (15) . An E^. coli vector, ST15/8.1, was constructed from pBR325 (16) Figure 1 ).
One microgram of human mtDNA digested with Kpnl and EcoRI was mixed with 0.2 ng of comparably digested ST15/8.1. The DNAs were ligated with T4 ligase (New England Bioiabs, Beverly, MA) (17) and the ligation mixtures were used to transform £. coli (18) . Colonies were screened for Ap-r, CAP-s and Tc-s. The piasmids were then extracted (19) and screened for the appropriate insert. Only two human mtDNA fragments are bounded by Kpnl and EcoRI sites, one of 3.4 Kb containing the unique BamHl site and the other of 1.5 Kb containing the rRNA genes (see Figure 1) . The plasmid containing the 1.5 Kb insert obtained from S3 mtDNA was designated ST27/10.1, those from 296-1 were ST25/9.1 and ST25/13.1, that from HT1080C was ST27/13.8 and that from HT102W was ST28/3.40. All of these plasmid inserts were confirmed by digestion with Xbal, Avail and Hpall which y i e l d distinctive fragment patterns for the 16S rRNA (1) . Experiments were performed under PI + EK1 containment consistent with the guidelines for recombinant DNA research set forth by the National Institutes of Health (20) .
DNA Sequencing
The DNA sequences were determined by the chemical method of Maxam and Gilbert (21) . 500 ml cultures of E_. c o l i bearing the plasmid were grown in LB medium (22) and extracted (23) .
The sequences for plasmids ST27/1O.1, ST25/13.1, ST27/13.8 and 
RESULTS

Drug Resistant Phenotypes of 296-1 and HT102W
HeLa CAP-r mutant 296-1 grows with essentially the same generation time in 25 and 50 ug/ml CAP and CAP concentrations of a t least 150 ug/ml have no effect on the 296-1 cloning efficiency. S3, by contrast, is f u l l y inhibited by 25 ug/ml (6,9) ( Table I ) for the cloned 1.5 Kb KpnI-EcoRI intDNA fragments of S3, 296-1, HT1080C and HT102W. This region encodes the 3' end of the 16S rRNA and encompasses the sites of the single nucleotide changes associated with CAP resistance R R in yeast mutants C^ and C^-The sequences of S3 mtDNA from the insert of plasmid ST27/10.1 and 296-1 mtDNA from the insert of ST25/13.1 were examined between nucleotides 2884 and 3064. The S3 mtDNA sequence was found to be identical with the previous L strand sequence obtained for placental mtDNA (1). S3 and 296-1 were found to d i f f e r by only a single nucleotide. This was a T to C transition at residue 2991. This sequence difference was confirmed by sequencing the H strand for 85 nucleotides from nucleotide 2954 to 3029. An A to G transition was found at position 2991. The sequence of the H strand for a second clone of 296-1 mtDNA (ST25/9.1) confirmed this result ruling out the possibility that the base change occurred during mtDNA cloning.
The nucleotide sequences in the region of the Xbal site of the 1.5 Kb KpnI-EcoRI fragment of HT1080C mtDNA (plasmid ST27/13.8) and HT102W mtDNA (plasmid ST28/8.40) were determined from nucleotide 2857 to 3047 on the L strand. As found for the HeLa samples, the HT1080C sequence was identical to the placental sequence (1). Likewise, HT102W was found to differ from HT1080C by a single C to A transversion at nucleotide 2939. This change was confirmed by sequencing from nucleotide 2874 to 2944 on the H strand where a G to T transversion was found at this same s i t e . Thus, in t h i s region of the 16S rRNA the S3 and HT1080C mtDNA sequences have been found to be identical to placental mtDNA while the 296-1 and HT102W sequences were found to d i f f e r from their parental sequences by a single nucleotide change. These two changes are themselves separated by 52 nucleotides though both are associated with CAP resistance.
DISCUSSION
Phenotypic and Structural Significance of Two Human CAP-r Mutations
We believe the two different substitutions observed in the two human mutants to be the molecular basis for the CAP-r phenotypes and not to be phenotypically neutral. The identification of other CAP-r mutants in this highly conserved region among different species strongly supports this conclusion and w i l l be detailed below. CAP is known to block the binding of aminoacyl-tRNA to the ribosome and thus i n h i b i t the peptidyl transferase reaction (25) . Because of the possible secondary structure of the rRNA in this region (26 and 11) which brings the two sites of mutation within 10 nucleotides of each other, these changes could easily affect the same enzymatic s i t e .
The parallel between the differences in 296-1 and HT102W CAP associated nucleotide changes and the differences in their CAP sensitivity raises the intriguing possiblity that these phenomena are causally related. The phenotypic differences are not simply the product of nuclear background for they are retained in reciprocal cybrid transfers where the nuclei are reversed (9,10). Though they might be explained by differences in the proportion of CAP-r and CAP-s mtDNAs within the c e l l , this possiblity seems unlikely since the mixing of CAP-s and CAP-r mtDNAs in cybrids and hybrids does not negate the association between the level of CAP resistance and the origin of the cellular mtDNA. The most reasonable conclusion is that the two different mutations y i e l d the two different phenotypes. Comparable phenotypic differences were also observed for the R R two yeast mutants, C 321 and C^ (27) . Thus, i t seems likely that different base changes in this region might result in a variety of CAP resistance phenotypes. More recently, the sequence in this region for the Physarum poiycephaiurn nuclear coded large rRNA gene (30) and for the corn chloroplast 23S rRNA gene (31) have been reported. The 3 mtDNA sequences and the corn chloroplast DNA sequence are identical in these two conserved regions. However, these sequences differ slightly from those of £. coli and Physarum. The 3 mtDHA rRNA sequences are compared to those of Z. coli and Physarum in Figure 3 .
In the 13 nucleotide box on the left of Figure 3 , the £. coli sequence differs from the Physarum sequence by 3 nucleotides and from the three mtDNAs by 2 nucleotides. The Physarum sequence differs from the three mtDNA sequences by 3 nucleotides as well. For the right hand 10 nucleotide box £. coli and the 3 mtDNAs share complete homology while Physarum differs from these sequences by 2 bases. These observations would be consistent with large rRNA of the mtDNA and chloroplast DNA being more closely related to the £. coli rRNA gene than to that of the Physarum nucleus.
It has been observed that the large rRNA gene of both S_. cerevisiae u+ strain mtDNA and Physarum nuclear DNA have an intron inserted at the same location in the 13 nucleotide conserved box. This result suggests that either there may be constraints on the possible locations of introns in this gene or that the mtONAs and Physarum nuclear DMA had a common ancestor with an intron in this position.
Sequence Comparisons of Different CAP-r Mutants
In addition to the nucleotide changes reported for the yeast CAP-r mutants C^i and C -^ (5) and the two human CAP-r mutants described here, we have previously described the nucleotide change associated with a mouse CAP-r mutant, 501-1 (11). Kearsey and Craig (32) have also described nucleotide changes for an independent HeLa CAP-r mutant, MC63, and a mouse 3T3 mutant, 3T3 CAP-r. The location of the associated nucleotide changes are indicated in Figure 3 by dots and the specific mutations shown in Figure 4 . A most striking correlation is seen for 3 of the 5 mammalian CAP-r mutants. HeLa mutants 296-1 and MC63 as well as mouse mutant 501-1 a l l have exactly the same nucleotide change, resulting in a U to C transition in the 10 nucleotide conserved box of the large rRNA. This change is one nucleotide 3 1 to the A to C transition P found for yeast mutant C,-]-I t seems extremely unlikely that chance alone could explain the appearance of these nucleotide changes in this highly conserved region in 3 independent CAP-r mutants. Rather, these changes must be associated with the CAP resistance phenotype. I t is further significant that a l l 3 of the CAP-r mutants have acquired a C in this location in the rRNA. The probability of a C being substituted in 3 independent t r i a l s by chance alone is less than 4 ((1/3) ). Consequently, i t is tempting to suggest that this base may alter the The remaining three CAP-r mutations are a l l located in the 13 nucleotide conserved box. The human HT102U mutation is due to a C to A transversion. The mouse 3T3 CAP-r mutation is immediately adjacent to that of HT102W and is an A to U transversion. Finally, the yeast mutation, Cjpot is 4 nucleotides 5' from the 3T3 CAP-r mutation and is a G to A transition. Since these mutations are dispersed over 6 nucleotides, these results suggest that more nucleotides of this region could be involved in the CAP binding site. Alternatively, additional constraints may be acting on the sequence of the right-hand 10 nucleotide box with the result that only a limited number of CAP-r mutants can be expressed.
One of the major phenotypic differences between cytosol 80S ribosomes and bacterial and mitochondrial ribosomes is their resistance to CAP. Though generally used as a major phenotypic t r a i t to argue for the similarity between organelle genomes and bacteria, the molecular basis of this difference remains unknown. The sequence of the CAP-r mutants in the 13 nucleotide conserved region could suggest an explanation. The Physarum 28S nuclear rRNA gene differs from the mtONA 16S rRNA gene and the E_. c o l i 23S rRNA gene by an A to U transversion in the 13 nucleotide box one nucleotide 3' to the CAP-r mutation of HT102W (Figure 3 ). This fact raises the intriguing possibility that this sequence change could have rendered the progenitors of the 80S ribosome CAP-r. Comparison with more eukaryotic nuclear rRNA sequences should help to confirm this hypothesis. Since the Archaebacteria have also been found to be CAP-r (33), i t w i l l be most interesting to examine the nucleotide sequence of their large rRNA genes in this region.
